UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A role for autophagy in the extension of lifespan by dietary restriction in C. elegans

PLoS genetics, 2008-02, Vol.4 (2), p.e24-e24

2008

Volltextzugriff (PDF)

Progranulin: at the interface of neurodegenerative and metabolic diseases

Trends in endocrinology and metabolism, 2013-12, Vol.24 (12), p.597-606

2013

Volltextzugriff (PDF)

Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut

Gastroenterology (New York, N.Y. 1943), 2001-02, Vol.120 (2), p.411-422

2001

Volltextzugriff (PDF)

Claudin-2 Forms Homodimers and Is a Component of a High Molecular Weight Protein Complex

The Journal of biological chemistry, 2011-02, Vol.286 (5), p.3442-3450

2011

Volltextzugriff (PDF)

SUMOylation of claudin-2

Annals of the New York Academy of Sciences, 2012-07, Vol.1258 (1), p.60-64

2012

Volltextzugriff (PDF)

MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2016, Vol.3 (1), p.91-97

2016

Volltextzugriff (PDF)

Expression, solubilization, and biochemical characterization of the tight junction transmembrane protein claudin‐4

Protein science, 2003-02, Vol.12 (2), p.218-227

2003

Volltextzugriff (PDF)

Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency

Frontiers in neurology, 2019-09, Vol.10, p.1004-1004

2019

Volltextzugriff (PDF)

An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations

Alzheimer's & dementia : translational research & clinical interventions, 2017-11, Vol.3 (4), p.507-512

2017

Volltextzugriff (PDF)

Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins

American journal of physiology: Gastrointestinal and liver physiology, 2000-08, Vol.279 (2), p.G250-G254

2000

Volltextzugriff (PDF)

Transmembrane proteins in the tight junction barrier

Journal of the American Society of Nephrology, 1999-06, Vol.10 (6), p.1337-1345

1999

Volltextzugriff (PDF)

Connexin-Occludin Chimeras Containing the ZO-Binding Domain of Occludin Localize at MDCK Tight Junctions and NRK Cell Contacts

The Journal of cell biology, 1999-08, Vol.146 (3), p.683-693

1999

Volltextzugriff (PDF)

The Neurofilament Surveillance Project (NSP): A biomarker study to sample blood quarterly in familial frontotemporal lobar degeneration

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

The role of neurofilament light in genetic frontotemporal lobar degeneration

Brain communications, 2023, Vol.5 (1), p.fcac310-fcac310

2023

Volltextzugriff (PDF)

Peripheral Innate Immune Activation Correlates with Disease Severity in GRN Mutation Carriers (P4.178)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Progranulin protein plasma and CSF levels in a large well-characterized dementia and healthy aging cohort. (S33.004)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development

Alzheimer's & dementia, 2013-03, Vol.9 (2), p.176-188

2013

Volltextzugriff (PDF)

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)

Alzheimer's & dementia, 2013-03, Vol.9 (2), p.189-198

2013

Volltextzugriff (PDF)

CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin

The Journal of biological chemistry, 2000-06, Vol.275 (24), p.18407-18417

2000

Volltextzugriff (PDF)

Comparative Biochemical and Immunocytochemical Studies Reveal Differences in the Effects of Clostridium perfringens Enterotoxin on Polarized CaCo-2 CellsVersus Vero Cells

The Journal of biological chemistry, 2001-09, Vol.276 (36), p.33402-33412

2001

Volltextzugriff (PDF)

Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells

The Journal of biological chemistry, 2001-09, Vol.276 (36), p.33402-33412

2001

Volltextzugriff (PDF)

CaCo-2 Cells Treated with Clostridium perfringensEnterotoxin Form Multiple Large Complex Species, One of Which Contains the Tight Junction Protein Occludin

The Journal of biological chemistry, 2000-06, Vol.275 (24), p.18407-18417

2000

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A role for autophagy in the extension of lifespan by dietary restriction in C. elegans

Progranulin: at the interface of neurodegenerative and metabolic diseases

Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut

Claudin-2 Forms Homodimers and Is a Component of a High Molecular Weight Protein Complex

Prosaposin is a regulator of progranulin levels and oligomerization

SUMOylation of claudin-2

MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes

Expression, solubilization, and biochemical characterization of the tight junction transmembrane protein claudin‐4

Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency

An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations

Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins

Transmembrane proteins in the tight junction barrier

Connexin-Occludin Chimeras Containing the ZO-Binding Domain of Occludin Localize at MDCK Tight Junctions and NRK Cell Contacts

CSF Proteomics in Patients With Progressive Supranuclear Palsy

The Neurofilament Surveillance Project (NSP): A biomarker study to sample blood quarterly in familial frontotemporal lobar degeneration

The role of neurofilament light in genetic frontotemporal lobar degeneration

Peripheral Innate Immune Activation Correlates with Disease Severity in GRN Mutation Carriers (P4.178)

Progranulin protein plasma and CSF levels in a large well-characterized dementia and healthy aging cohort. (S33.004)

Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)

CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin

Comparative Biochemical and Immunocytochemical Studies Reveal Differences in the Effects of Clostridium perfringens Enterotoxin on Polarized CaCo-2 CellsVersus Vero Cells

Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells

Frontotemporal Degeneration, the Next Therapeutic Frontier: Molecules and Animal Models for FTD drug development (Part 1 of 2 articles)

CaCo-2 Cells Treated with Clostridium perfringensEnterotoxin Form Multiple Large Complex Species, One of Which Contains the Tight Junction Protein Occludin

Suchergebnisse filtern